Welcome to our dedicated page for Pathward Financial SEC filings (Ticker: CASH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how Pathward Financial, Inc. (ticker CASH) juggles consumer refund advance loans, Banking-as-a-Service deposits and commercial insurance premium finance can feel like piecing together a 300-page puzzle. When segments swing with tax season, investors need more than a PDF download鈥攖hey need answers.
Stock Titan鈥檚 AI reads every Pathward Financial quarterly earnings report 10-Q filing, flags each Pathward Financial 8-K material events explained, and decodes the footnotes in the Pathward Financial annual report 10-K simplified. Our platform converts dense credit-quality tables into plain-language trends, highlights capital ratios, and sends instant alerts on Pathward Financial Form 4 insider transactions real-time. Curious about executive pay? Jump straight to the Pathward Financial proxy statement executive compensation section. Need to see if directors are buying? The dedicated feed surfaces Pathward Financial insider trading Form 4 transactions and links them to market-moving 8-Ks. All of this lives inside a single page of Pathward Financial SEC filings explained simply, no jargon required.
- Compare tax-season revenue spikes across years with AI-generated charts.
- Monitor Pathward Financial executive stock transactions Form 4 alongside deposit-cost disclosures.
- Receive concise 鈥渨hy it matters鈥� notes for new partner banking agreements announced in 8-Ks.
- Export AI summaries for audit, lending, or compliance reviews.
Whether you鈥檙e hunting for Pathward Financial earnings report filing analysis or simply understanding Pathward Financial SEC documents with AI, Stock Titan delivers every page the moment it hits EDGAR and translates it into decisions you can act on.
Alvotech鈥檚 July 2025 Form 6-K details governance, commercial, regulatory and financing actions since its Q1 report.
- Governance: Six directors re-elected; veteran executive Linda J贸nsd贸ttir appointed CFO; COO Faysal Kalmoua exits board and management.
- Commercial: Advanz Pharma partnership broadened to three new biosimilars (milestones up to 鈧�160 m) and separate AVT10 (Cimzia) deal; global Keytruda biosimilar co-development with Dr. Reddy鈥檚.
- M&A: Acquired Swiss packager Ivers-Lee and Xbrane鈥檚 Swedish R&D team plus Cimzia candidate for c.SEK 275 m.
- Pipeline: CHMP positive opinion for AVT06 (Eylea); AVT23 (Xolair) study shows therapeutic equivalence.
- Manufacturing risk: FDA pre-approval inspection (26 Jun鈥�4 Jul) issued Form 483 citing operational, documentation and quality control deficiencies; detailed response submitted 25 Jul.
- Financing: Oversubscribed SDR IPO (SEK 39 m) and institutional placement (SEK 750 m) add >3,000 new holders; term-loan amendment folds second tranche, trims margin to SOFR+6.0%, facility now $1.081 bn, cash $152 m.
New capital and partnerships enhance growth prospects, but regulatory remediation is critical for near-term BLA approvals.
Dimensional Fund Advisors LP (DFA) has filed a Schedule 13G indicating that, as of 30 June 2025, it beneficially owns 1,572,330 shares of Boston Omaha Corp ("BOC"), representing 5.1 % of the company鈥檚 outstanding common stock. The institutional investor reports sole voting power over 1,540,879 shares and sole dispositive power over the full 1,572,330-share position, with no shared voting or dispositive authority.
DFA, a Delaware limited partnership and SEC-registered investment adviser, explains that the shares are held across multiple mutual funds, commingled trusts and separate accounts for which it or its subsidiaries act as adviser or sub-adviser. While DFA may exercise voting and investment discretion, it expressly disclaims beneficial ownership in excess of the requirements of Section 13(d).
Crossing the 5 % ownership threshold triggers this disclosure and signals a modest increase in institutional ownership in BOC. Because DFA is predominantly a passive, quantitative manager, the filing does not suggest an activist agenda or an intention to influence control. Nevertheless, additional institutional sponsorship can enhance liquidity, broaden research coverage and potentially support the share price through index-related demand.
Key numeric details
- Date of event: 30 June 2025
- Shares owned: 1,572,330
- Percent of class: 5.1 %
- Sole voting power: 1,540,879
- Sole dispositive power: 1,572,330
Overall, the Schedule 13G is an informative but routine ownership disclosure that underscores growing passive interest in Boston Omaha without materially altering corporate governance or near-term strategy.
Alarum Technologies Ltd. (NASDAQ: ALAR) has filed a Form 6-K to furnish notice and proxy materials for its Annual and Extraordinary General Meeting of Shareholders, scheduled for 7 August 2025 at 3:00 p.m. Israel time. Only holders of ordinary shares or American Depositary Shares (ADSs) of record at the close of business on 9 July 2025 may vote.
The filing attaches four exhibits: (1) meeting notice, (2) proxy statement, (3) proxy card, and (4) ADS voting instruction form. No financial statements, earnings data, or transaction details are included. The Form 6-K is automatically incorporated by reference into several outstanding S-8 and F-3 registration statements, a routine step to keep those documents current.
From an investment perspective, the submission is procedural rather than financial; it simply initiates the annual corporate governance cycle and enables shareholders to vote on proposals that will be described in the proxy statement (not supplied here). The filing does not signal any immediate change in Alarum鈥檚 operations, strategy, or financial outlook.
FAQ
What is the current stock price of Pathward Financial (CASH)?
What is the market cap of Pathward Financial (CASH)?
What is the core business of Pathward Financial?
How does Pathward Financial generate revenue?
What distinguishes Pathward's Consumer segment?
How is the Commercial segment structured?
What role do corporate services play in the company?
How does Pathward Financial maintain its competitive edge?
How does the company integrate financial technology into its services?
What are the key partnerships that support Pathward鈥檚 operations?
